We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+7.5%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$69.4B
AUM Growth
+$3.09B
(+4.7%)
Cap. Flow
-$1.1B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
1,637
New
142
Increased
674
Reduced
560
Closed
116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$313M |
| 2 |
Visa
V
|
+$211M |
| 3 |
Brookfield Asset Management
BAM
|
+$201M |
| 4 |
Roper Technologies
ROP
|
+$103M |
| 5 |
Gartner
IT
|
+$82.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$417M |
| 2 |
ON Semiconductor
ON
|
+$286M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$140M |
| 4 |
Bank of Montreal
BMO
|
+$128M |
| 5 |
Toronto Dominion Bank
TD
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.36% |
| 2 | Technology | 19.76% |
| 3 | Industrials | 13.24% |
| 4 | Healthcare | 9.04% |
| 5 | Energy | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
MillerKnoll
MLKN
$1.62B
| $210K | ﹤0.01% |
8,486
-4,248
| -33% | -$120K |
|
1327
Iovance Biotherapeutics
IOVA
$1.92B
| $210K | ﹤0.01% |
+14,163
| New | +$165K |
|
1328
Ingevity
NGVT
$2.54B
| $210K | ﹤0.01% |
4,397
| – | – |
|
1329
Arrowhead Research
ARWR
$11.8B
| $209K | ﹤0.01% |
+7,299
| New | +$233K |
|
|
TBI
1330
Trueblue
TBI
$231M
| $209K | ﹤0.01% |
16,657
+5,881
| +55% | +$76K |
|
1331
Corcept Therapeutics
CORT
$12.4B
| $208K | ﹤0.01% |
8,259
+1,811
| +28% | +$42.8K |
|
|
JBTM
1332
JBT Marel
JBTM
$7.37B
| $207K | ﹤0.01% |
+1,978
| New | +$197K |
|
1333
Myers Industries
MYE
$1.3B
| $207K | ﹤0.01% |
+8,935
| New | +$177K |
|
1334
Mistras Group
MG
$490M
| $207K | ﹤0.01% |
21,647
+3,849
| +22% | +$32.1K |
|
1335
Procore
PCOR
$8.33B
| $207K | ﹤0.01% |
+2,514
| New | +$187K |
|
|
SFBS
1336
ServisFirst Bancshares
SFBS
$4.9B
| $206K | ﹤0.01% |
3,111
| – | – |
|
1337
Amylyx Pharmaceuticals
AMLX
$2.19B
| $206K | ﹤0.01% |
+72,572
| New | +$949K |
|
1338
Ormat Technologies
ORA
$5.93B
| $205K | ﹤0.01% |
3,097
| – | – |
|
1339
Vericel Corp
VCEL
$2.42B
| $204K | ﹤0.01% |
+3,924
| New | +$172K |
|
|
SWTX
1340
DELISTED
SpringWorks Therapeutics
SWTX
| $204K | ﹤0.01% |
+4,137
| New | +$191K |
|
|
KEEL
1341
Keel Infrastructure Corp
KEEL
$2.54B
| $204K | ﹤0.01% |
91,565
+4,719
| +5% | +$12.3K |
|
1342
Visteon
VC
$2.79B
| $203K | ﹤0.01% |
1,730
| – | – |
|
|
ACLX
1343
DELISTED
Arcellx
ACLX
| $203K | ﹤0.01% |
+2,912
| New | +$185K |
|
|
SEM
1344
DELISTED
Select Medical
SEM
| $202K | ﹤0.01% |
+12,437
| New | +$182K |
|
|
VGR
1345
DELISTED
Vector Group Ltd.
VGR
| $202K | ﹤0.01% |
18,394
+5,705
| +45% | +$62K |
|
1346
SLR Investment Corp
SLRC
$704M
| $202K | ﹤0.01% |
13,133
+133
| +1% | +$2.01K |
|
1347
NorthWestern Energy
NWE
$4.24B
| $201K | ﹤0.01% |
3,942
+1
| +0% | +$49 |
|
|
YALA
1348
Yalla Group
YALA
$827M
| $201K | ﹤0.01% |
+41,717
| New | +$215K |
|
1349
Varex Imaging
VREX
$499M
| $196K | ﹤0.01% |
10,806
+425
| +4% | +$7.8K |
|
|
PARA
1350
DELISTED
Paramount Global Class B
PARA
| $196K | ﹤0.01% |
16,616
+1,789
| +12% | +$22.5K |
|
Similar funds
Mackenzie Financial's Q1 2024 Portfolio in Review
As of Q1 2024, Mackenzie Financial held 1,637 positions worth $69.4B, up 4.7% from $66.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Mackenzie Financial's Q1 2024 filing shows 142 new, 674 increased, 560 reduced and 116 closed positions. Its largest new stake was Cognex: 1,284,682 shares worth $54.5M. The largest sale was Synopsys, an estimated $417M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
- Mackenzie Financial's largest Q1 2024 buy was Cognex: 1,284,682 shares worth $54.5M.
- Mackenzie Financial added most to Cadence Design Systems in Q1 2024, an estimated $313M increase.
- Mackenzie Financial's biggest Q1 2024 reduction was Synopsys, cutting an estimated $417M.
- Mackenzie Financial fully exited Alteryx Inc in Q1 2024, selling an estimated $140M.
- Mackenzie Financial's ten largest holdings make up 22% of its $69.4B portfolio in Q1 2024.
- Mackenzie Financial opened 142 new positions and closed 116 in Q1 2024.
- Mackenzie Financial's portfolio value rose 4.7% quarter-over-quarter to $69.4B.
Based on Mackenzie Financial's 13F filing for Q1 2024, filed 10 May 2024.